Creative Medical Technology Receives Nasdaq Notice Over Minimum Bid Price Noncompliance

PUBT · 1d ago
Creative Medical Technology Receives Nasdaq Notice Over Minimum Bid Price Noncompliance
  • Creative Medical Technology Holdings received a Nasdaq noncompliance notice on November 10, 2026, for violating minimum bid-price Rule 5550(a)(2).
  • The common stock's closing bid price remained below $1 for 30 consecutive business days. The notice has no immediate listing impact.
  • The company has a 180-day grace period, until May 10, 2027, to regain compliance.
  • Compliance requires the common stock's bid price to close at $1 or more for at least 10 consecutive business days.
  • An additional 180-day extension may be available if the company meets Nasdaq Capital Market initial listing standards, excluding minimum bid price.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Creative Medical Technology Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-006933), on November 13, 2026, and is solely responsible for the information contained therein.